- Home
- SOPA vs ADIL Comparison
SOPA vs ADIL Comparison
Compare SOPA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPA | ADIL |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.8M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SOPA | ADIL |
|---|---|---|
| Price | $1.14 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $18.00 | $1.50 |
| AVG Volume (30 Days) | 105.6K | ★ 350.5K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,227,427.00 | N/A |
| Revenue This Year | $26.32 | N/A |
| Revenue Next Year | $13.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.65 | N/A |
| 52 Week Low | $0.64 | $0.22 |
| 52 Week High | $6.75 | $1.30 |
Technical Indicators
Market Signals| Indicator | SOPA | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 35.83 | 32.77 |
| Support Level | $1.25 | $0.30 |
| Resistance Level | $1.40 | $0.32 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 3.51 | 1.31 |
Price Performance
Historical ComparisonAbout SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.